B
BSIM Therapeutics, S.A.
Profile managed by Bizz IdBSIM Therapeutics
Portugal
1-10 employees
2011
Description
Academic spinoff founded in 2011 from research at the University of Coimbra and University of Leeds. Develops innovative medicines for rare neurodegenerative diseases, focused on transthyretin-mediated amyloidosis (hATTR). Uses molecular modeling, cheminformatics and machine learning. Backed by Portugal Ventures and Bluepharma.